NORAD and cancer: Notably, a specific group of lncRNAs named hypoxia-responsive lncRNAs (HRLs) can be modulated by hypoxic tumor microenvironment, such as NORAD, RAB11B-AS1, and AC020978, are involved in cancer progression [18–20].